Liquid biopsy in mamma carcinoma

Liquid biopsy in mamma carcinoma - LiBiMa

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON51488

Enrollment

100

Registered

2023-02-07

Start date

2022-12-15

Completion date

Unknown

Last updated

2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mamma carcinoma metastasized triple negative mammacarcinoma

Interventions

None listed

Eligibility

Age

16 Years to 99 Years

Inclusion criteria

Inclusion criteria: - patients with a metastasized mammacarcinoma

Exclusion criteria

Exclusion criteria: - no other malignancies - no biopt of the primary tumor - patients younger than 16 years - no informed consent

Design outcomes

Primary

Measure	Time frame
- relation between de absence/presence of specific PIK3CA mutations in blood vs primary tumor	—

Secondary

Measure	Time frame
- relation between de absence/presence of specific PIK3CAmutations in urine vs peripheral blood	—

Countries

Netherlands

Outcome results